HOME | 中文 | ENGLISH
Home
About Us
Wuxi Beita
Changsha Beita
Cooperation Units
Intellectual Property
Academic Publications
Qualification
Products
Radioisotope Labeled Products
Stable Isotope Labeled Products
Services
Technology Advantages
Labeling Service
Detection and Analysis Services
Customers
News
Beita News
Industry News
Media Coverage
Contact Us
Feedback
Information List
Academician Li Zhaoshen Calls for Gastric Cancer Screening to Rise to National Plan (PG, G-17, Hp Concerned)
2018-04-17
In Vitro Diagnostic Network April 17, 2018 Reducing the incidence and mortality of gastric cancer in my country has always been an important issue to be resolved in the field of public health. Recently, China's early gastric cancer screening process expert consensus (draft) published, the consensus to further refine the "China early gastric cancer screening and endoscopic diagnosis and treatment consensus (2014, Changsha)" and establish suitable for China's national conditions of early gastric cancer screening process. Li Zhaoshen: Call for gastric cancer screening to rise to the national plan to "eliminate" the only way for advanced cancer. Academician Li Zhaoshen said that corresponding to the high incidence of digestive tract tumors, China
Research Status of Radioisotope Carbon -14 Labeled Synthesis in China
2018-02-25
National Science and Technology Progress Award: Eradication of Helicobacter pylori, effective prevention of gastric cancer
2018-01-19
Source: Dr. Cheng on Digestion 2018-01-19 Author: Dr. Cheng Hong On January 8, 2017, the 2017 National Science and Technology Awards Conference was held ceremoniously in the Great Hall of the People in Beijing. Peking University medical three outstanding science and technology successfully won the second prize of the National Science and Technology Progress Award. In the achievements of "the creation and application of key technologies of comprehensive prevention and control system of gastric cancer" with Professor Ji Jiafu of Peking University Cancer Hospital as the first person, the feasible strategy of gastric cancer prevention and control was pioneered in the world to effectively reduce the risk of gastric cancer. It is the first and currently the only prospective randomized controlled intervention study in the world.
Wuxi Beta establishes cooperative relationship with China Academy of Engineering Physics
2018-01-13
On January 31, 2018, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the Second Institute of China Academy of Engineering Physics signed a memorandum of cooperation to cooperate in the development of my country's C14 source materials and tracer technology, promote military-civilian integration, and nuclear technology in the medical and medical fields Application to benefit human health.
Wuxi Beta Obtain High-tech Enterprise Certificate
2017-12-07
On December 7, 2017, Wuxi Beta Pharmaceutical Technology Co., Ltd. obtained the certificate of high-tech enterprise in Jiangsu Province. So far, Wuxi Beta has obtained a total of 16 patents, published 9 academic papers in well-known journals and academic conferences at home and abroad, overcome a number of technical difficulties, created 5 "gold standard" products and technologies, and developed more than 400 kinds of isotope labeling products. These technological innovations have brought broad development prospects to Wuxi Beta.
Two Australians saved 0.8 billion lives in China! So won the Nobel Prize!
2017-08-22
2017-08-2216:41 Microbiology On December 10, 2005, the annual Nobel Prize Ceremony was held as scheduled in Stockholm, Sweden. When the dean of the Karolinska Institute announced the ownership of the medical award that year, the flash of the audience gathered on the two Australians. Rubin Warren (RobinWarren) and Barry Marshall (BarryMarshall), these two names will be solemnly recorded in history from that moment on-their understanding of "Helicobacterpylori-secluded."
Changsha is expected to produce carbon -13 labeled products and detection reagents.
2017-07-05
Xinhua News Agency, December 5 (Reporter Xiong Yuanfan) at the 2014 Human Resources work Conference of Changsha Economic Development Zone held today, seven entrepreneurial and innovative projects, such as "Development of carbon -13 isotope labeled precursor compounds and internal standard detection reagents", received financial support from 6.3 million yuan, and carbon -13 labeled products and detection reagents are expected to be manufactured in Changsha. Newborns are screened for genetic and metabolic diseases, and the key substance in the kit used for testing is carbon -13 or carbon -14. These two carbon isotopes are widely used for labeling bioactive molecules, labeling biological test reagents and small molecule pharmaceuticals. For example, gastric cancer patients carry stomach
Nobel Prize Winner Joins Hands with Jiangyin Enterprise to Set up Research Institute
2017-07-03
Reprint: Jiangsu Science and Technology News (correspondent Liu Jiajia, Li Neng and reporter Ma Yang) On the morning of November 23, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the 2005 Nobel Prize winner in chemistry and California Institute of Technology professor Robert Grubb The China (Jiangyin) Research Institute for Isotope Labeling was officially unveiled, and the Chinese Academy of Engineering Academician Zhou Yongmao's workstation was also established. The Grubb Isotope Labeling China (Jiangyin) Research Institute is led by Professor Robert Grubb, relying on the world-leading laboratory technology platform of Beta Pharmaceutical Company to research and innovate 13C, 14C and other isotope labeling products.
Grubb Isotope Labeling China (Jiangyin) Research Institute Settles in High-tech Zone
2017-07-02
Reprint: On the morning of November 23, China Jiangyin Party and Government Network, Grubb Isotope Labeling China (Jiangyin) Research Institute and Academician Zhou Yongmao's Workstation held an inauguration ceremony. So far, our city has introduced 5 high-end talents who have won the Nobel Prize, of which 4 have set up research institutes in Jiangyin, and 36 academician workstations have settled in our city. Robert Grubb, Nobel Laureate in Chemistry and professor of the California Institute of Technology, Zhou Yongmao, academician of the Chinese Academy of Engineering, and city leaders Shen Jian, Qian Wenqin, Feng Aidong, Fei Ping, and Yu Xinquan attended the inauguration ceremony. Municipal Standing Committee, Organization Department Minister Qian Wenqin presided over the ceremony. Mayor Shen Jianzhi
Grubb Isotope Labeling China (Jiangyin) Research Institute Unveiled
2017-07-01
Reprint: The original title of People's Daily Online: Jiangyin once again joined hands with the Nobel Prize winner. On the morning of November 23, the Grubb isotope marker created by Wuxi Beta Pharmaceutical Technology Co., Ltd. and Nobel Prize winner in chemistry and California Institute of Technology Professor Robert Grubb The China (Jiangyin) Research Institute was officially unveiled, and Academician Zhou Yongmao's workstation was also established. This is the fourth Nobel laureate research institute and the 36th academician workstation established since Jiangyin vigorously implemented the "talent strengthening enterprise 330 plan", which fully demonstrates the achievements of the city's talent recruitment work. It is reported that the Grubb isotope labeling China (Jiangyin) Research Institute by Robert Guerra
● Beita News
● Industry News
● Media Coverage